Immunocore Holdings plc (IMCR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Immunocore Holdings plc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -66.15x | -36.14x | -60.03x | -49.62x | -8.05x | -13.56x |
| P/B Ratio | 4.59x | 4.09x | 9.00x | 6.36x | 4.64x | 18.16x |
| P/S Ratio | 5.87x | 5.95x | 13.31x | 14.95x | 39.74x | 33.37x |
| Profitability | ||||||
| Gross Margin | 97.9% | 97.8% | 99.6% | 96.3% | 100.0% | -148.4% |
| Operating Margin | -11.3% | -22.7% | -23.9% | -29.7% | -478.5% | -286.2% |
| Net Margin | -8.9% | -16.5% | -22.2% | -30.1% | -493.4% | -246.0% |
| EBITDA Margin | 0.1% | -15.5% | -20.7% | -26.6% | -457.0% | -273.6% |
| Liquidity | ||||||
| Current Ratio | 4.04x | 4.38x | 3.80x | 4.70x | 4.29x | 2.78x |
| Quick Ratio | 4.01x | 4.36x | 3.77x | 4.69x | 4.29x | 2.90x |
| Leverage | ||||||
| Debt/Equity | 0.11x | 1.20x | 0.23x | 0.24x | 0.37x | 1.35x |
YoY = year-over-year change. Source: FMP..